Entera Bio (ENTX) Intangibles (2017 - 2018)
Entera Bio (ENTX) recorded quarterly Intangibles of $651000.0 in Q4 2018, little changed on a QoQ basis from $654000.0 in Q4 2017, and little changed year-over-year from $654000.0 in Q4 2017.
Entera Bio (ENTX) Intangibles (2017 - 2018) Analysis & Trends
Entera Bio has disclosed Intangibles across 2 years of filings, most recently posting $651000.0 for Q4 2018.
- Quarterly Intangibles changed 0.46% year-over-year to $651000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $651000.0 (changed 0.46% YoY) and the FY2018 annual result came in at $651000.0, changed 0.46% from the prior year.
- Intangibles held at $651000.0 in Q4 2018, from $654000.0 in the prior quarter.
- Over five years, Intangibles peaked at $654000.0 in Q4 2017 and troughed at $651000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 7.73 Mn |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 651,000.00 |
| Dec 31, 2017 | 654,000.00 |